GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Change In Receivables

Pacific Biosciences of California (STU:P09) Change In Receivables : €-7.8 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Change In Receivables?

Pacific Biosciences of California's change in receivables for the quarter that ended in Jun. 2024 was €-2.0 Mil. It means Pacific Biosciences of California's Accounts Receivable increased by €2.0 Mil from Mar. 2024 to Jun. 2024 .

Pacific Biosciences of California's change in receivables for the fiscal year that ended in Dec. 2023 was €-16.3 Mil. It means Pacific Biosciences of California's Accounts Receivable increased by €16.3 Mil from Dec. 2022 to Dec. 2023 .

Pacific Biosciences of California's Accounts Receivable for the quarter that ended in Jun. 2024 was €30.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Pacific Biosciences of California's Days Sales Outstanding for the three months ended in Jun. 2024 was 82.18.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pacific Biosciences of California's liquidation value for the three months ended in Jun. 2024 was €-416.5 Mil.


Pacific Biosciences of California Change In Receivables Historical Data

The historical data trend for Pacific Biosciences of California's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Change In Receivables Chart

Pacific Biosciences of California Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.00 -1.32 -6.34 5.15 -16.35

Pacific Biosciences of California Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.13 -6.05 -5.62 5.79 -1.96

Pacific Biosciences of California Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Biosciences of California  (STU:P09) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pacific Biosciences of California's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=30.13/33.456*91
=82.18

2. In Ben Graham's calculation of liquidation value, Pacific Biosciences of California's accounts receivable are only considered to be worth 75% of book value:

Pacific Biosciences of California's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=473.606-944.599+0.75 * 30.13+0.5 * 63.724
=-416.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Biosciences of California Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Pacific Biosciences of California Headlines

No Headlines